Restoring Blood Flow.
Treating today's atherosclerotic disease requires a new generation of tools for better outcomes.
Opening Blocked Arteries Requires a New Approach
An aging population and unhealthy lifestyles make atherosclerotic disease a leading health issue throughout the world.
A Global Health
Improving Angioplasty For Better Outcomes
Over 1,000 times more focal force than a plain balloon.
A Proven Technology
Based on physics principles, focused force along multiple interrupted points results in a controlled, predictable cracking effect, even at low pressure.
What are Physicians Saying?
Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication
Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, also announces completion of its PRELUDE-BTK clinical trial enrollment.